Cyclo Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:CYTH   3:59:53 PM EDT
2.14
+0.16 (+8.08%)
Earnings Announcements

Cyclo Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/12/2022 20:32 GMT
Cyclo Therapeutics Inc - Ordinary Shares - Class A (CYTH) - Cyclo Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results.
Cyclo Therapeutics - Qtrly Loss per Share $0.33.
Revenue is expected to be $0.57 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0.62 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.